No Data
Exact Sciences Is Maintained at Outperform by Evercore ISI Group
Exact Sciences Is Maintained at Outperform by Evercore ISI Group
Evercore ISI Group Maintains Outperform on Exact Sciences, Lowers Price Target to $72
Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $80 to $72.
Exact Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 67.42% Evercore ISI Group $80 → $72 Maintains Outperform 06/27/2024 62.77% BTIG $80 → $70 Maint
Evercore Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72
Evercore analyst Vijay Kumar maintains $Exact Sciences(EXAS.US)$ with a buy rating, and adjusts the target price from $90 to $72.According to TipRanks data, the analyst has a success rate of 47.4% and
Express News | Geneoscopy: Confident Litigation Will Not Delay Commercial Launch of Colosense
Express News | Geneoscopy: Files Counterclaims Against Exact Sciences